MicroRNA-9 induces defective trafficking of Nav1.1 and Nav1.2 by targeting Navβ2 protein coding region in rat with chronic brain hypoperfusion

Molecular Neurodegeneration

Volumn 10, Issue 1, 2015, Pages

  Sun, Li Hua ^a   Yan, Mei Ling ^a   Hu, Xue Ling ^a   Peng, Li Wei ^a   Che, Hui ^a   Bao, Ya Nan ^a   Guo, Fei ^a   Liu, Tong ^a   Chen, Xin ^a   Zhang, Rong ^a   Ban, Tao ^a   Wang, Ning ^a   Liu, Huai Lei ^a   Hou, Xu ^a   Ai, Jing ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Chronic brain hypoperfusion; microRNA 9; Sodium channel

Indexed keywords

LENTIVIRUS VECTOR; MICRORNA 9; SODIUM CHANNEL NAV1.1; SODIUM CHANNEL NAV1.2; ANTISENSE OLIGONUCLEOTIDE; MICRORNA; MIRN9 MICRORNA, RAT; NERVE PROTEIN; SCN1A PROTEIN, RAT; SODIUM; VOLTAGE GATED SODIUM CHANNEL BETA 2 SUBUNIT; VOLTAGE GATED SODIUM CHANNEL BLOCKING AGENT;

AMINO ACID BRAIN LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN CORTEX; BRAIN ISCHEMIA; BRAIN PERFUSION; CELL MEMBRANE; COMMON CAROTID ARTERY; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; GENE CONTROL; GENE FUNCTION; GENE MUTATION; GENE OVEREXPRESSION; GENE SILENCING; HIPPOCAMPUS; MALE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN TARGETING; PROTEIN TRANSPORT; RAT; ANIMAL; BIOSYNTHESIS; CHRONIC DISEASE; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; LENTIVIRINAE; LIGATION; METABOLISM; PHARMACOLOGY; PROTEIN TERTIARY STRUCTURE; SPRAGUE DAWLEY RAT;

LENTIVIRUS; RATTUS;

ANIMALS; BRAIN ISCHEMIA; CAROTID ARTERY, COMMON; CEREBRAL CORTEX; CHRONIC DISEASE; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GENETIC VECTORS; HIPPOCAMPUS; LENTIVIRUS; LIGATION; MALE; MICRORNAS; NAV1.1 VOLTAGE-GATED SODIUM CHANNEL; NAV1.2 VOLTAGE-GATED SODIUM CHANNEL; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; SODIUM; VOLTAGE-GATED SODIUM CHANNEL BETA-2 SUBUNIT; VOLTAGE-GATED SODIUM CHANNEL BLOCKERS;

EID: 84938897329     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/s13024-015-0032-9     Document Type: Article

References (63)

1. Brackenbury WJ, Isom LL. Na Channel beta Subunits: Overachievers of the Ion Channel Family. Front Pharmacol. 2011;2:53.
2. Eijkelkamp N, Linley JE, Baker MD, Minett MS, Cregg R, Werdehausen R, et al. Neurological perspectives on voltage-gated sodium channels. Brain. 2012;135:2585-612.
3. Abdelsayed M, Sokolov S. Voltage-gated sodium channels: pharmaceutical targets via anticonvulsants to treat epileptic syndromes. Channels (Austin). 2013;7:146-52.
4. Mantegazza M, Curia G, Biagini G, Ragsdale DS, Avoli M. Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders. Lancet Neurol. 2010;9:413-24.
5. Tarnawa I, Bolcskei H, Kocsis P. Blockers of voltage-gated sodium channels for the treatment of central nervous system diseases. Recent Pat CNS Drug Discov. 2007;2:57-78.
6. Amatniek JC, Hauser WA, DelCastillo-Castaneda C, Jacobs DM, Marder K, Bell K, et al. Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia. 2006;47:867-72.
7. Bakker A, Krauss GL, Albert MS, Speck CL, Jones LR, Stark CE, et al. Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron. 2012;74:467-74.
8. Sanchez PE, Zhu L, Verret L, Vossel KA, Orr AG, Cirrito JR, et al. Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model. Proc Natl Acad Sci U S A. 2012;109:E2895-2903.
9. Palop JJ, Mucke L. Epilepsy and cognitive impairments in Alzheimer disease. Arch Neurol. 2009;66:435-40.
10. Born HA, Kim JY, Savjani RR, Das P, Dabaghian YA, Guo Q, et al. Genetic suppression of transgenic APP rescues Hypersynchronous network activity in a mouse model of Alzeimer's disease. J Neurosci S. 2014;34:3826-40.
11. Bender AC, Morse RP, Scott RC, Holmes GL, Lenck-Santini PP. SCN1A mutations in Dravet syndrome: impact of interneuron dysfunction on neural networks and cognitive outcome. Epilepsy Behav. 2012;23:177-86.
12. Kim DY, Carey BW, Wang H, Ingano LA, Binshtok AM, Wertz MH, et al. BACE1 regulates voltage-gated sodium channels and neuronal activity. Nat Cell Biol. 2007;9:755-64.
13. Verret L, Mann EO, Hang GB, Barth AM, Cobos I, Ho K, et al. Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell. 2012;149:708-21.
14. Hu X, Zhou X, He W, Yang J, Xiong W, Wong P, et al. BACE1 deficiency causes altered neuronal activity and neurodegeneration. J Neurosci. 2010;30:8819-29.
15. Maschietto M, Girardi S, Dal Maschio M, Scorzeto M, Vassanelli S. Sodium channel beta2 subunit promotes filopodia-like processes and expansion of the dendritic tree in developing rat hippocampal neurons. Front Cell Neurosci. 2013;7:2.
16. Chen C, Calhoun JD, Zhang Y, Lopez-Santiago L, Zhou N, Davis TH, et al. Identification of the cysteine residue responsible for disulfide linkage of Na + channel alpha and beta2 subunits. J Biol Chem. 2012;287:39061-9.
17. Isom LL, Ragsdale DS, De Jongh KS, Westenbroek RE, Reber BF, Scheuer T, et al. Structure and function of the beta 2 subunit of brain sodium channels, a transmembrane glycoprotein with a CAM motif. Cell. 1995;83:433-42.
18. Chen C, Bharucha V, Chen Y, Westenbroek RE, Brown A, Malhotra JD, et al. Reduced sodium channel density, altered voltage dependence of inactivation, and increased susceptibility to seizures in mice lacking sodium channel beta 2-subunits. Proc Natl Acad Sci U S A. 2002;99:17072-7.
19. Huth T, Alzheimer C. Voltage-dependent Na + channels as targets of BACE1 - implications for neuronal firing and beyond. Curr Alzheimer C. 2012;9:184-8.
20. Corbett BF, Leiser SC, Ling HP, Nagy R, Breysse N, Zhang X, et al. Sodium channel cleavage is associated with aberrant neuronal activity and cognitive deficits in a mouse model of Alzheimer's disease. J Neurosci. 2013;33:7020-6.
21. Kitaguchi H, Tomimoto H, Ihara M, Shibata M, Uemura K, Kalaria RN, et al. Chronic cerebral hypoperfusion accelerates amyloid beta deposition in APPSwInd transgenic mice. Brain Res. 2009;1294:202-10.
22. Zhiyou C, Yong Y, Shanquan S, Jun Z, Liangguo H, Ling Y, et al. Upregulation of BACE1 and beta-amyloid protein mediated by chronic cerebral hypoperfusion contributes to cognitive impairment and pathogenesis of Alzheimer's disease. Neurochem Res. 2009;34:1226-35.
23. Ruitenberg A, den Heijer T, Bakker SL, van Swieten JC, Koudstaal PJ, Hofman A, et al. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol. 2005;57:789-94.
24. Ai J, Sun LH, Che H, Zhang R, Zhang TZ, Wu WC, et al. MicroRNA-195 protects against dementia induced by chronic brain hypoperfusion via its anti-amyloidogenic effect in rats. J Neurosci. 2013;33:3989-4001.
25. Farkas E, Institoris A, Domoki F, Mihaly A, Bari F. The effect of pre- and posttreatment with diazoxide on the early phase of chronic cerebral hypoperfusion in the rat. Brain Res. 2006;1087:168-74.
26. Liu HX, Zhang JJ, Zheng P, Zhang Y. Altered expression of MAP-2, GAP-43, and synaptophysin in the hippocampus of rats with chronic cerebral hypoperfusion correlates with cognitive impairment. Brain ResMol Brain Res. 2005;139:169-77.
27. Ren L, Wang YK, Fang YN, Zhang AW, Li XL. Effect of electroacupuncture therapy on the expression of Na(v)1.1 and Na(v)1.6 in rat after acute cerebral ischemia. Neurol Res. 2010;32:1110-6.
28. Deo M, Yu JY, Chung KH, Tippens M, Turner DL. Detection of mammalian microRNA expression by in situ hybridization with RNA oligonucleotides. Dev Dyn. 2006;235:2538-48.
29. Shibata M, Nakao H, Kiyonari H, Abe T, Aizawa S. MicroRNA-9 regulates neurogenesis in mouse telencephalon by targeting multiple transcription factors. J Neurosci. 2011;31:3407-22.
30. Hu Y, Luo M, Ni N, Den Y, Xia J, Chen J, et al. Reciprocal Actions of microRNA-9 and TLX in the Proliferation and Differentiation of Retinal Progenitor Cells. Stem Cells Dev. 2014;23(22):2771-81.
31. Zhao C, Sun G, Li S, Shi Y. A feedback regulatory loop involving microRNA-9 and nuclear receptor TLX in neural stem cell fate determination. Nat Struc Mol Biol. 2009;16:365-71.
32. Pietrzykowski AZ, Friesen RM, Martin GE, Puig SI, Nowak CL, Wynne PM, et al. Posttranscriptional regulation of BK channel splice variant stability by miR-9 underlies neuroadaptation to alcohol. Neuron. 2008;59:274-87.
33. Coolen M, Thieffry D, Drivenes O, Becker TS, Bally-Cuif L. miR-9 controls the timing of neurogenesis through the direct inhibition of antagonistic factors. Dev Cell. 2012;22:1052-64.
34. Zhao C, Sun G, Ye P, Li S, Shi Y. MicroRNA let-7d regulates the TLX/microRNA-9 cascade to control neural cell fate and neurogenesis. Sci Rep. 2013;3:1329.
35. Tan X, Wang S, Yang B, Zhu L, Yin B, Chao T, et al. The CREB-miR-9 negative feedback minicircuitry coordinates the migration and proliferation of glioma cells. PloS One. 2012;7:e49570.
36. Dajas-Bailador F, Bonev B, Garcez P, Stanley P, Guillemot F, Papalopulu N: microRNA-9 regulates axon extension and branching by targeting Map1b in mouse cortical neurons. Nat Neurosci 2012;15:697-699.
37. Otaegi G, Pollock A, Sun T. An Optimized Sponge for microRNA miR-9 Affects Spinal Motor Neuron Development in vivo. Front Neurosci. 2011;5:146.
38. Packer AN, Xing Y, Harper SQ, Jones L, Davidson BL. The bifunctional microRNA miR-9/miR-9∗regulates REST and CoREST and is downregulated in Huntington's disease. J Neurosci. 2008;28:14341-6.
39. Lukiw WJ. Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. Neuroreport. 2007;18:297-300.
40. Lai HC, Jan LY. The distribution and targeting of neuronal voltage-gated ion channels. Nat Rev Neurosci. 2006;7:548-62.
41. Saba R, Schratt GM. MicroRNAs in neuronal development, function and dysfunction. Brain Res. 2010;1338:3-13.
42. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15-20.
43. Reczko M, Maragkakis M, Alexiou P, Grosse I, Hatzigeorgiou AG. Functional microRNA targets in protein coding sequences. Bioinformatics. 2012;28:771-6.
44. Ogata N, Ohishi Y. Molecular diversity of structure and function of the voltage-gated Na + channels. Jpn J Pharmacol. 2002;88:365-77.
45. Leterrier C, Brachet A, Fache MP, Dargent B. Voltage-gated sodium channel organization in neurons: protein interactions and trafficking pathways. Neurosci Lett. 2010;486:92-100.
46. Duflocq A, Le Bras B, Bullier E, Couraud F, Davenne M. Nav1.1 is predominantly expressed in nodes of Ranvier and axon initial segments. Mol Cell Neurosci. 2008;39:180-92.
47. Lorincz A, Nusser Z. Cell-type-dependent molecular composition of the axon initial segment. J Neurosci. 2008;28:14329-40.
48. Kim DY, Gersbacher MT, Inquimbert P, Kovacs DM. Reduced sodium channel Na(v)1.1 levels in BACE1-null mice. J Bbiol Chem. 2011;286:8106-16.
49. Kovacs DM, Gersbacher MT, Kim DY. Alzheimer's secretases regulate voltage-gated sodium channels. Neurosci Lett. 2010;486:68-72.
50. Gersbacher MT, Kim DY, Bhattacharyya R, Kovacs DM. Identification of BACE1 cleavage sites in human voltage-gated sodium channel beta 2 subunit. Mol Neurodegener. 2010;5:61.
51. Diakov A, Bera K, Mokrushina M, Krueger B, Korbmacher C. Cleavage in the {gamma}-subunit of the epithelial sodium channel (ENaC) plays an important role in the proteolytic activation of near-silent channels. J Physiol. 2008;586:4587-608.
52. Harris M, Firsov D, Vuagniaux G, Stutts MJ, Rossier BC. A novel neutrophil elastase inhibitor prevents elastase activation and surface cleavage of the epithelial sodium channel expressed in Xenopus laevis oocytes. J Biol Chem. 2007;282:58-64.
53. Kim DY, Ingano LA, Carey BW, Pettingell WH, Kovacs DM. Presenilin/gamma-secretase-mediated cleavage of the voltage-gated sodium channel beta2-subunit regulates cell adhesion and migration. J Biol Chem. 2005;280:23251-61.
54. Sethi P, Lukiw WJ. Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex. Neurosci Lett. 2009;459:100-4.
55. Cogswell JP, Ward J, Taylor IA, Waters M, Shi Y, Cannon B, et al. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis. 2008;14:27-41.
56. Schonrock N, Humphreys DT, Preiss T, Gotz J. Target gene repression mediated by miRNAs miR-181c and miR-9 both of which are down-regulated by amyloid-beta. J Mol Neurosci. 2012;46:324-35.
57. Duursma AM, Kedde M, Schrier M, le Sage C, Agami R. miR-148 targets human DNMT3b protein coding region. RNA. 2008;14:872-7.
58. Zhou X, Duan X, Qian J, Li F. Abundant conserved microRNA target sites in the 5'-untranslated region and coding sequence. Genetica. 2009;137:159-64.
59. Huang S, Wu S, Ding J, Lin J, Wei L, Gu J, et al. MicroRNA-181a modulates gene expression of zinc finger family members by directly targeting their coding regions. Nucleic acids Res. 2010;38:7211-8.
60. Goswami S, Tarapore RS, Teslaa JJ, Grinblat Y, Setaluri V, Spiegelman VS. MicroRNA-340-mediated degradation of microphthalmia-associated transcription factor mRNA is inhibited by the coding region determinant-binding protein. Biol Chem. 2010;285:20532-40.
61. Long Q, Johnson BA, Osunkoya AO, Lai YH, Zhou W, Abramovitz M, et al. Protein-coding and microRNA biomarkers of recurrence of prostate cancer following radical prostatectomy. Am J Patho. 2011;179:46-54.
62. Kumaran D, Udayabanu M, Kumar M, Aneja R, Katyal A. Involvement of angiotensin converting enzyme in cerebral hypoperfusion induced anterograde memory impairment and cholinergic dysfunction in rats. Neuroscience. 2008;155:626-39.
63. Zhuang G, Wu X, Jiang Z, Kasman I, Yao J, Guan Y, et al. Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J. 2012;31:3513-23.